Literature DB >> 20504239

Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

Paul M Lantos1, William A Charini, Gerald Medoff, Manuel H Moro, David M Mushatt, Jeffrey Parsonnet, John W Sanders, Carol J Baker.   

Abstract

In April 2008, the Infectious Diseases Society of America (IDSA) entered into an agreement with Connecticut Attorney General Richard Blumenthal to voluntarily undertake a special review of its 2006 Lyme disease guidelines. This agreement ended the Attorney General's investigation into the process by which the guidelines were developed. The IDSA agreed to convene an independent panel to conduct a one-time review of the guidelines. The Review Panel members, vetted by an ombudsman for potential conflicts of interest, reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations devoted to post-Lyme disease syndromes. After multiple meetings, a public hearing, and extensive review of research and other information, the Review Panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504239     DOI: 10.1086/654809

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Protracted neuroborreliosis--an unusual cause of encephalomyelitis.

Authors:  Saif Huda; Udo Carl Wieshmann
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  International consensus on periprosthetic joint infection: description of the consensus process.

Authors:  William Cats-Baril; Thorsten Gehrke; Katherine Huff; Daniel Kendoff; Mitchell Maltenfort; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-10-24       Impact factor: 4.176

3.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 4.  Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases.

Authors:  Holger J Schünemann
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 5.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

6.  Lyme disease in Canada: Focus on children.

Authors:  Heather Onyett
Journal:  Paediatr Child Health       Date:  2014-08       Impact factor: 2.253

7.  Lymelight: forecasting Lyme disease risk using web search data.

Authors:  Adam Sadilek; Yulin Hswen; John S Brownstein; Evgeniy Gabrilovich; Shailesh Bavadekar; Tomer Shekel
Journal:  NPJ Digit Med       Date:  2020-02-04

Review 8.  Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Authors:  Emir Hodzic
Journal:  Bosn J Basic Med Sci       Date:  2015-07-08       Impact factor: 3.363

Review 9.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

10.  The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines.

Authors:  Lorraine Johnson; Raphael B Stricker
Journal:  Philos Ethics Humanit Med       Date:  2010-06-09       Impact factor: 2.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.